Cargando...
Drug therapy in anticoagulation: which drug for which patient?
Four non-vitamin K oral anticoagulants (NOACs) are now licensed and available in the UK, offering unprecedented choices in anticoagulant therapy for clinicians and patients. NOACs have many clear benefits over warfarin, the most striking being the reduction in intracranial haemorrhage. However, a nu...
Guardado en:
| Publicado en: | Clin Med (Lond) |
|---|---|
| Autores principales: | , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
Royal College of Physicians
2017
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6297571/ https://ncbi.nlm.nih.gov/pubmed/28572224 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7861/clinmedicine.17-3-233 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|